About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker BCYC

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Jul 6, 2026Jennifer Scott Perry
Chief Operating Officer
BCYC
Bicycle Therapeutics plc
Sale333$4.34$1,445 SaleForm 4 ↗
Jul 6, 2026Jennifer Scott Perry
Chief Operating Officer
BCYC
Bicycle Therapeutics plc
Sale43$4.31$185 SaleForm 4 ↗
Jul 6, 2026Michael Charles Ferguson Hannay
CHIEF PROD & SUPPLY CHAIN OFF
BCYC
Bicycle Therapeutics plc
Sale255$4.31$1,099 SaleForm 4 ↗
Jul 6, 2026Travis Alvin Thompson
Chief Financial Officer
BCYC
Bicycle Therapeutics plc
Sale104$4.31$448 SaleForm 4 ↗
Jul 6, 2026Kevin Lee
CHIEF EXECUTIVE OFFICER, Director
BCYC
Bicycle Therapeutics plc
Sale1,737$4.31$7,486 SaleForm 4 ↗
Jul 6, 2026Michael Skynner
CHIEF SCIENTIFIC OFFICER
BCYC
Bicycle Therapeutics plc
Sale532$4.31$2,293 SaleForm 4 ↗
Jul 2, 2026Jennifer Scott Perry
Chief Operating Officer
BCYC
Bicycle Therapeutics plc
Sale1,036$4.27$4,424 SaleForm 4 ↗
Jul 2, 2026Michael Charles Ferguson Hannay
CHIEF PROD & SUPPLY CHAIN OFF
BCYC
Bicycle Therapeutics plc
Sale1,506$4.27$6,431 SaleForm 4 ↗
Jul 2, 2026Travis Alvin Thompson
Chief Financial Officer
BCYC
Bicycle Therapeutics plc
Sale819$4.27$3,497 SaleForm 4 ↗
Jul 2, 2026Kevin Lee
CHIEF EXECUTIVE OFFICER, Director
BCYC
Bicycle Therapeutics plc
Sale5,905$4.27$25.2K SaleForm 4 ↗
Jul 2, 2026Michael Skynner
CHIEF SCIENTIFIC OFFICER
BCYC
Bicycle Therapeutics plc
Sale1,859$4.27$7,938 SaleForm 4 ↗
Apr 6, 2026Jennifer Scott Perry
Chief Operating Officer
BCYC
Bicycle Therapeutics plc
Sale333$5.04$1,678 SaleForm 4 ↗
Apr 6, 2026Jennifer Scott Perry
Chief Operating Officer
BCYC
Bicycle Therapeutics plc
Sale37$5.05$187 SaleForm 4 ↗
Apr 6, 2026Michael Charles Ferguson Hannay
CHIEF PROD & SUPPLY CHAIN OFF
BCYC
Bicycle Therapeutics plc
Sale251$5.05$1,268 SaleForm 4 ↗
Apr 6, 2026Travis Alvin Thompson
Chief Financial Officer
BCYC
Bicycle Therapeutics plc
Sale102$5.05$515 SaleForm 4 ↗
Apr 6, 2026Kevin Lee
CHIEF EXECUTIVE OFFICER, Director
BCYC
Bicycle Therapeutics plc
Sale1,716$5.05$8,666 SaleForm 4 ↗
Apr 6, 2026Michael Skynner
CHIEF SCIENTIFIC OFFICER
BCYC
Bicycle Therapeutics plc
Sale525$5.05$2,651 SaleForm 4 ↗
Apr 2, 2026Jennifer Scott Perry
Chief Operating Officer
BCYC
Bicycle Therapeutics plc
Sale1,038$4.91$5,097 SaleForm 4 ↗
Apr 2, 2026Michael Charles Ferguson Hannay
CHIEF PROD & SUPPLY CHAIN OFF
BCYC
Bicycle Therapeutics plc
Sale1,521$4.91$7,468 SaleForm 4 ↗
Apr 2, 2026Travis Alvin Thompson
Chief Financial Officer
BCYC
Bicycle Therapeutics plc
Sale799$4.91$3,923 SaleForm 4 ↗
Apr 2, 2026Kevin Lee
CHIEF EXECUTIVE OFFICER, Director
BCYC
Bicycle Therapeutics plc
Sale5,967$4.91$29.3K SaleForm 4 ↗
Apr 2, 2026Michael Skynner
CHIEF SCIENTIFIC OFFICER
BCYC
Bicycle Therapeutics plc
Sale1,879$4.91$9,226 SaleForm 4 ↗
Jan 5, 2026Michael Charles Ferguson Hannay
CHIEF PROD & SUPPLY CHAIN OFF
BCYC
Bicycle Therapeutics plc
Sale2,367$6.45$15.3K SaleForm 4 ↗
Jan 5, 2026Travis Alvin Thompson
CHIEF ACCOUNTING OFFICER
BCYC
Bicycle Therapeutics plc
Sale1,115$6.45$7,192 SaleForm 4 ↗
Jan 5, 2026Alethia Young
Chief Financial Officer
BCYC
Bicycle Therapeutics plc
Sale1,878$6.54$12.3K SaleForm 4 ↗
Jan 5, 2026Alethia Young
Chief Financial Officer
BCYC
Bicycle Therapeutics plc
Sale2,456$6.45$15.8K SaleForm 4 ↗
Jan 5, 2026Alistair Milnes
CHIEF OPERATING OFFICER
BCYC
Bicycle Therapeutics plc
Sale3,416$6.46$22.1K SaleForm 4 ↗
Jan 5, 2026Kevin Lee
CHIEF EXECUTIVE OFFICER, Director
BCYC
Bicycle Therapeutics plc
Sale10,989$6.46$71.0K SaleForm 4 ↗
Jan 5, 2026Michael Skynner
CHIEF TECHNOLOGY OFFICER
BCYC
Bicycle Therapeutics plc
Sale3,266$6.46$21.1K SaleForm 4 ↗
Jan 2, 2026Michael Charles Ferguson Hannay
CHIEF PROD & SUPPLY CHAIN OFF
BCYC
Bicycle Therapeutics plc
Sale2,827$6.80$19.2K SaleForm 4 ↗
Jan 2, 2026Travis Alvin Thompson
CHIEF ACCOUNTING OFFICER
BCYC
Bicycle Therapeutics plc
Sale1,317$6.80$8,956 SaleForm 4 ↗
Jan 2, 2026Alethia Young
Chief Financial Officer
BCYC
Bicycle Therapeutics plc
Sale3,289$6.80$22.4K SaleForm 4 ↗
Jan 2, 2026Alistair Milnes
CHIEF OPERATING OFFICER
BCYC
Bicycle Therapeutics plc
Sale3,244$6.80$22.1K SaleForm 4 ↗
Jan 2, 2026Kevin Lee
CHIEF EXECUTIVE OFFICER, Director
BCYC
Bicycle Therapeutics plc
Sale10,325$6.80$70.2K SaleForm 4 ↗
Jan 2, 2026Michael Skynner
CHIEF TECHNOLOGY OFFICER
BCYC
Bicycle Therapeutics plc
Sale3,045$6.80$20.7K SaleForm 4 ↗
Oct 3, 2025Michael Charles Ferguson Hannay
CHIEF PROD & SUPPLY CHAIN OFF
BCYC
Bicycle Therapeutics plc
Sale250$8.41$2,103 SaleForm 4 ↗
Oct 3, 2025Travis Alvin Thompson
CHIEF ACCOUNTING OFFICER
BCYC
Bicycle Therapeutics plc
Sale103$8.41$866 SaleForm 4 ↗
Oct 3, 2025Alistair Milnes
CHIEF OPERATING OFFICER
BCYC
Bicycle Therapeutics plc
Sale978$8.41$8,225 SaleForm 4 ↗
Oct 3, 2025Kevin Lee
CHIEF EXECUTIVE OFFICER, Director
BCYC
Bicycle Therapeutics plc
Sale3,231$8.41$27.2K SaleForm 4 ↗
Oct 3, 2025Michael Skynner
CHIEF TECHNOLOGY OFFICER
BCYC
Bicycle Therapeutics plc
Sale978$8.41$8,225 SaleForm 4 ↗
Oct 2, 2025Robert Charles Swanton
Director
BCYC
Bicycle Therapeutics plc
Sale102$8.55$872 SaleForm 4 ↗
Oct 2, 2025Michael Charles Ferguson Hannay
CHIEF PROD & SUPPLY CHAIN OFF
BCYC
Bicycle Therapeutics plc
Sale473$8.40$3,973 SaleForm 4 ↗
Oct 2, 2025Travis Alvin Thompson
CHIEF ACCOUNTING OFFICER
BCYC
Bicycle Therapeutics plc
Sale221$8.40$1,856 SaleForm 4 ↗
Oct 2, 2025Alethia Young
Chief Financial Officer
BCYC
Bicycle Therapeutics plc
Sale265$8.61$2,282 SaleForm 4 ↗
Oct 2, 2025Alethia Young
Chief Financial Officer
BCYC
Bicycle Therapeutics plc
Sale217$8.40$1,823 SaleForm 4 ↗
Oct 2, 2025Alistair Milnes
CHIEF OPERATING OFFICER
BCYC
Bicycle Therapeutics plc
Sale1,147$8.40$9,635 SaleForm 4 ↗
Oct 2, 2025Kevin Lee
CHIEF EXECUTIVE OFFICER, Director
BCYC
Bicycle Therapeutics plc
Sale2,263$8.40$19.0K SaleForm 4 ↗
Oct 2, 2025Michael Skynner
CHIEF TECHNOLOGY OFFICER
BCYC
Bicycle Therapeutics plc
Sale824$8.40$6,922 SaleForm 4 ↗
Jul 3, 2025Kevin Lee
CHIEF EXECUTIVE OFFICER, Director
BCYC
Bicycle Therapeutics plc
Sale3,193$7.44$23.8K SaleForm 4 ↗
Jul 3, 2025Michael Skynner
CHIEF TECHNOLOGY OFFICER
BCYC
Bicycle Therapeutics plc
Sale966$7.44$7,187 SaleForm 4 ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:44 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances